Lyophilized Human Recombinant Interferon-beta 1a FP-1201 - CISMeF
Lyophilized Human Recombinant Interferon-beta 1a FP-1201NCIt concept
Preferred Label : Lyophilized Human Recombinant Interferon-beta 1a FP-1201;
NCIt synonyms : Traumakine (TM); Lyophilized Human Recombinant IFN-b-1a FP-1201; Lyophilized Human Recombinant IFN-beta-1a FP-1201; Lyophilized rhIFNb-1a FP-1201;
NCIt definition : A lyophilized form of recombinant human interferon (IFN) beta-1a (rhIFNb-1a), with
potential protective activity. Upon dissolution of lyophilized rhIFNb-1a FP-1201 and
intravenous administration, IFNb-1a upregulates the expression of and increases the
levels of 5'-nucleotidase (CD73). This induces adenosine monophosphate (AMP) degradation
and the production of adenosine. Adenosine acts to enhance endothelial barrier function
via adenosine receptor activation and may prevent or reduce the increased vascular
leakage that is due to the lack of adenosine. By increasing adenosine, rhIFNb-1a may
protect the lining of blood vessels and thereby reduce inflammation. In addition,
FP-1201 may prevent cytokine release syndrome (CRS) and immune effector cell associated-neurotoxicity
syndrome (ICANS) toxicities in certain patients receiving CAR T-cell therapy. CD73
is abundantly expressed by normal endothelial cells.;